SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Tender Offer

10 Nov 2011 09:41

RNS Number : 8545R
J.P. Morgan Private Equity Ltd
10 November 2011
 



 

J.P. MORGAN PRIVATE EQUITY LIMITEDANNOUNCES INTENT TO OPERATE TENDER FACILITY FOR THE PERIODENDING 31 DECEMBER 2011

 

* * *

 

GUERNSEY, 10 NOVEMBER 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce its intent to make a tender offer to purchase up to 3% of US$ Equity Shares, 2013 ZDP Shares and 2015 ZDP Shares, respectively, currently in issue (excluding shares held in treasury) (the "Shares").

 

JPEL's Board of Directors intends to make a formal announcement regarding the operation of the Company's tender facility in due course. Shares will be tendered based on the prevailing net asset value (NAV) as at 31 December 2011.

 

"Returning capital to shareholders at prevailing NAV is a significant priority and is a direct result of the Company's strong balance sheet and distribution activity." said Trevor Ash, JPEL's Chairman. "When distribution activity is sufficient, we look to reward shareholders with the ability to periodically tender shares at NAV. JPEL is the only listed private equity fund to offer such a tender facility. Since its IPO in 2005, JPEL has returned over $127 million to shareholders through redemptions, tenders and market buy backs."

 

The terms and conditions of the tender offer and instructions on how shareholders may participate in the tender offer will be set forth in a Circular to be published once the Company makes a formal announcement. The Company will hold Shares tendered in treasury, subject to compliance with all regulatory limits. At this time, no tender will be made for 2017 ZDP Shares as there is currently no shareholder authority for the Company to tender 2017 ZDP Shares. JPEL intends to seek the authority to tender up to 15 per cent. of all classes of shares currently in issue at the Company's next annual general meeting to be held in 2012.

 

JPEL remains focused on maintaining a strong balance sheet. As such, the operation of the tender facility will be subject to various factors including positive distribution activity from the Company's underlying private equity investments and the overall health of the global economy. Therefore, JPEL's Board of Directors and the Manager will continue to monitor cash flows from JPEL's underlying investments in order to determine timing and appropriate levels for future tender offers. JPEL's Board of Directors continues to believe that its highest obligation during periods of economic uncertainty is to keep the Company healthy and strong for the future.

 

* * *

ENQUIRIES

 

J.P. Morgan Private Equity Limited 

Troy Duncan: Tel (Direct): +44 207 742 3032 (troy.duncan@jpmorgan.com)

Gregory Getschow: Tel (Direct): +1 212 648 1150 (gregrory.getschow@jpmorgan.com)

Rosemary DeRise: Tel (Direct): +1 212 648 2980 (rosemary.derise@jpmorgan.com)

Samantha Ladd: Tel (Direct): +1 212 648 2982 (samantha.ladd@jpmorgan.com)

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEANFEFDNFFEF
Date   Source Headline
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company
15th Nov 201710:11 amRNSRetirement of 2017 ZDP Shares
9th Nov 20177:00 amRNS2017 AGM CIRCULAR
27th Oct 20174:33 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNet Asset Value(s) - September 2017
17th Oct 20179:40 amRNSDirector Declaration
13th Oct 20177:00 amRNSTiming of Retirement of 2017 ZDP Shares
11th Oct 20177:00 amRNSBerkshire Partners Acquires Accela
28th Sep 20177:00 amRNSAnnual Financial Report
27th Sep 20179:45 amRNSDirector Update
26th Sep 201711:11 amRNSNet Asset Value(s) - August 2017
7th Sep 20177:00 amRNSNet Asset Value(s) - July 2017
21st Aug 20172:21 pmRNSHolding(s) in Company
3rd Aug 20177:00 amRNSNet Asset Value(s) - June 2017
5th Jul 20175:50 pmRNSNet Asset Value(s) - May 2017 Correction
30th Jun 20179:52 amRNSNet Asset Value(s) - May 2017
2nd Jun 20177:00 amRNSNet Asset Value(s) - April 2017
30th May 20174:34 pmRNSHolding(s) in Company
25th May 20174:42 pmRNSHolding(s) in Company
2nd May 20173:50 pmRNSNotice to Shareholders - Total Voting Rights
2nd May 20177:00 amRNSCompletion of Mandatory Redemption_ April 2017
24th Apr 20176:15 pmRNSNotification of Dealings in Shares
21st Apr 20177:00 amRNSQuarter End Review for March 2017
12th Apr 20177:00 amRNSMandatory Redemption_US$ Equity Shares_April 2017
11th Apr 20175:22 pmRNSNet Asset Value(s) - March 2017
7th Apr 20177:00 amRNSNet Asset Value(s) - February 2017
28th Mar 20174:56 pmRNSHalf-year Report
16th Mar 20176:04 pmRNSSale of Datamars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.